Earnings Outlook For DiaMedica Therapeutics
Portfolio Pulse from Benzinga Insights
DiaMedica Therapeutics (NASDAQ:DMAC) is expected to release its quarterly earnings report on Monday, 2023-11-13, with analysts predicting an EPS of $-0.13. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, DMAC's stock price has reacted to both earnings outcomes and guidance. Last quarter, DMAC beat the EPS estimate by $0.02, leading to a 4.4% stock price increase the following day. Over the last year, DMAC shares have risen by 101.7%, trading at $2.35 as of November 09.
November 10, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DiaMedica Therapeutics is anticipated to report quarterly earnings with an EPS of $-0.13. A positive earnings surprise and guidance could lead to a stock price increase, as seen historically.
Given DMAC's history of stock price increases following an earnings beat and the overall 101.7% increase over the past year, a positive report and guidance are likely to result in a short-term price increase. However, the market's reaction can be unpredictable, and external factors could also influence the stock's performance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100